Product Information
DOXYCYCLINE 25 MG/5 ML SUSP is a generic product labeled by Chartwell RX LLC, priced at $0.2304 per ML under NDC 62135041746. Its NADAC has been published 321 times since Aug 12, 2020.
FDA first approved this application on Jul 16, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/5mL
Manufacturer
Chartwell RX LLCNDC
62135041746
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOXYCYCLINEApproval Type
Generic (ANDA)
FDA Application
ANDA065454FDA Approved
7/16/2008
TE Code
AB
On Market Since
7/16/2008
Pharmacological Classes
Price Statistics
The NADAC for DOXYCYCLINE 25 MG/5 ML SUSP has been published 321 times since Aug 12, 2020, and over the history we have for it it has declined 11.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2304 per ML |
|---|---|
| All-time high | $0.2825 (Jun 14, 2023) |
| All-time low | $0.1814 (Nov 20, 2024) |
| 52-week high | $0.2341 |
| 52-week low | $0.2164 |
| Median price | $0.2323 |
| Average price | $0.2362 |
| Largest weekly change | -20.7% (Jun 21, 2023) |
| Weeks tracked | 321 |
| Tracking since | Aug 12, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
doxycycline market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tetracycline-class Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DOXYCYCLINE 25 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for DOXYCYCLINE 25 MG/5 ML SUSP, manufactured by Chartwell RX LLC, is $0.2304 per ML (NDC 62135041746), effective Sep 30, 2026.
How has the price of DOXYCYCLINE 25 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for DOXYCYCLINE 25 MG/5 ML SUSP has declined 11.5%. It has been tracked across 321 weekly CMS publications since Aug 12, 2020.
What are the highest and lowest recorded NADAC prices for DOXYCYCLINE 25 MG/5 ML SUSP?
Since Aug 12, 2020, the NADAC for DOXYCYCLINE 25 MG/5 ML SUSP has ranged from a low of $0.1814 (Nov 20, 2024) to a high of $0.2825 (Jun 14, 2023), with a median of $0.2323 per ML.
Are there cheaper alternatives to DOXYCYCLINE 25 MG/5 ML SUSP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DOXYCYCLINE 25 MG/5 ML SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures DOXYCYCLINE 25 MG/5 ML SUSP?
DOXYCYCLINE 25 MG/5 ML SUSP (NDC 62135041746) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.